BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Maclean C, Moenning U, Reichel A, Fricker G. Regional absorption of fexofenadine in rat intestine. European Journal of Pharmaceutical Sciences 2010;41:670-4. [DOI: 10.1016/j.ejps.2010.09.007] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Hens B, Gonzalez-alvarez I, Bermejo M. Exploring the Predictive Power of the In Situ Perfusion Technique towards Drug Absorption: Theory, Practice, and Applications. Mol Pharmaceutics. [DOI: 10.1021/acs.molpharmaceut.1c00861] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Hussner J, Foletti A, Seibert I, Fuchs A, Schuler E, Malagnino V, Grube M, Meyer Zu Schwabedissen HE. Differences in transport function of the human and rat orthologue of the Organic Anion Transporting Polypeptide 2B1 (OATP2B1). Drug Metab Pharmacokinet 2021;41:100418. [PMID: 34628357 DOI: 10.1016/j.dmpk.2021.100418] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Takahashi Y, Narumi K, Nadai T, Ueda H, Yamamura T, Furugen A, Kobayashi M. In vitro and in vivo evaluation of organic anion-transporting polypeptide 2B1-mediated pharmacokinetic interactions by apple polyphenols. Xenobiotica 2021;:1-8. [PMID: 34396892 DOI: 10.1080/00498254.2021.1969480] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Kondo A, Narumi K, Okuhara K, Takahashi Y, Furugen A, Kobayashi M, Iseki K. Black tea extract and theaflavin derivatives affect the pharmacokinetics of rosuvastatin by modulating organic anion transporting polypeptide (OATP) 2B1 activity. Biopharm Drug Dispos 2019;40:302-6. [PMID: 31400238 DOI: 10.1002/bdd.2202] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
5 Zhang J, Xie Q, Kong W, Wang Z, Wang S, Zhao K, Chen Y, Liu X, Liu L. Short-chain fatty acids oppositely altered expressions and functions of intestinal cytochrome P4503A and P-glycoprotein and affected pharmacokinetics of verapamil following oral administration to rats. J Pharm Pharmacol 2020;72:448-60. [PMID: 31863502 DOI: 10.1111/jphp.13215] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
6 Wang Z, Yang H, Xu J, Zhao K, Chen Y, Liang L, Li P, Chen N, Geng D, Zhang X, Liu X, Liu L. Prediction of Atorvastatin Pharmacokinetics in High-Fat Diet and Low-Dose Streptozotocin-Induced Diabetic Rats Using a Semiphysiologically Based Pharmacokinetic Model Involving Both Enzymes and Transporters. Drug Metab Dispos 2019;47:1066-79. [PMID: 31399507 DOI: 10.1124/dmd.118.085902] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
7 Aboulfotouh K, Allam AA, El-badry M, El-sayed AM. Self-emulsifying drug–delivery systems modulate P-glycoprotein activity: role of excipients and formulation aspects. Nanomedicine 2018;13:1813-34. [DOI: 10.2217/nnm-2017-0354] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
8 Murakami T. Absorption sites of orally administered drugs in the small intestine. Expert Opin Drug Discov 2017;12:1219-32. [PMID: 28920464 DOI: 10.1080/17460441.2017.1378176] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 5.8] [Reference Citation Analysis]
9 Turkanovic J, Ward MB, Gerber JP, Milne RW. Effect of Garlic, Gingko, and St. John's Wort Extracts on the Pharmacokinetics of Fexofenadine: A Mechanistic Study. Drug Metab Dispos 2017;45:569-75. [PMID: 28188296 DOI: 10.1124/dmd.116.073528] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
10 Li F, Xu D, Shu N, Zhong Z, Zhang M, Liu C, Ling Z, Liu L, Liu X. Co-administration of paroxetine increased the systemic exposure of pravastatin in diabetic rats due to the decrease in liver distribution. Xenobiotica 2015;45:794-802. [PMID: 25915109 DOI: 10.3109/00498254.2015.1019592] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
11 Stappaerts J, Brouwers J, Annaert P, Augustijns P. In situ perfusion in rodents to explore intestinal drug absorption: challenges and opportunities. Int J Pharm 2015;478:665-81. [PMID: 25448559 DOI: 10.1016/j.ijpharm.2014.11.035] [Cited by in Crossref: 46] [Cited by in F6Publishing: 48] [Article Influence: 5.8] [Reference Citation Analysis]
12 Zakeri-milani P, Valizadeh H. Intestinal transporters: enhanced absorption through P-glycoprotein-related drug interactions. Expert Opinion on Drug Metabolism & Toxicology 2014;10:859-71. [DOI: 10.1517/17425255.2014.905543] [Cited by in Crossref: 48] [Cited by in F6Publishing: 50] [Article Influence: 6.0] [Reference Citation Analysis]
13 Misaka S, Miyazaki N, Fukushima T, Yamada S, Kimura J. Effects of green tea extract and (−)-epigallocatechin-3-gallate on pharmacokinetics of nadolol in rats. Phytomedicine 2013;20:1247-50. [DOI: 10.1016/j.phymed.2013.07.003] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
14 Stappaerts J, Annaert P, Augustijns P. Site dependent intestinal absorption of darunavir and its interaction with ketoconazole. European Journal of Pharmaceutical Sciences 2013;49:51-6. [DOI: 10.1016/j.ejps.2013.01.015] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
15 Arakawa H, Shirasaka Y, Haga M, Nakanishi T, Tamai I. Active intestinal absorption of fluoroquinolone antibacterial agent ciprofloxacin by organic anion transporting polypeptide, Oatp1a5: OATP-MEDIATED ABSORPTION OF CIPROFLOXACIN. Biopharm Drug Dispos 2012;33:332-41. [DOI: 10.1002/bdd.1809] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 3.5] [Reference Citation Analysis]
16 Biopharmaceutical Modeling for Miscellaneous Cases. Biopharmaceutics Modeling and Simulations 2012. [DOI: 10.1002/9781118354339.ch13] [Reference Citation Analysis]
17 Suzuki K, Shitara Y, Fukuda K, Horie T. Long-Lasting Inhibition of the Intestinal Absorption of Fexofenadine by Cyclosporin a in Rats. Journal of Pharmaceutical Sciences 2012;101:2606-15. [DOI: 10.1002/jps.23174] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
18 Shirasaka Y, Suzuki K, Nakanishi T, Tamai I. Differential Effect of Grapefruit Juice on Intestinal Absorption of Statins Due to Inhibition of Organic Anion Transporting Polypeptide and/or P-glycoprotein. Journal of Pharmaceutical Sciences 2011;100:3843-53. [DOI: 10.1002/jps.22586] [Cited by in Crossref: 49] [Cited by in F6Publishing: 49] [Article Influence: 4.5] [Reference Citation Analysis]
19 Gundogdu E, Mangas-sanjuan V, Gonzalez-alvarez I, Bermejo M, Karasulu E. In vitro–in situ permeability and dissolution of fexofenadine with kinetic modeling in the presence of sodium dodecyl sulfate. Eur J Drug Metab Pharmacokinet 2012;37:65-75. [DOI: 10.1007/s13318-011-0059-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]